Correlation Between Janux Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Janux Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Janux Therapeutics and Edgewise Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Janux and Edgewise is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Janux Therapeutics is expected to under-perform the Edgewise Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Janux Therapeutics is 1.14 times less risky than Edgewise Therapeutics. The stock trades about -0.21 of its potential returns per unit of risk. The Edgewise Therapeutics is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest 3,481 in Edgewise Therapeutics on August 24, 2024 and sell it today you would lose (283.00) from holding Edgewise Therapeutics or give up 8.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Janux Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Janux Therapeutics |
| Edgewise Therapeutics |
Janux Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Janux Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Janux Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute |
| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |